海外の治験の状況「1」での検索結果
11240件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Recruiting
- PGC-1 & MUSCLE MITOCHONDRIAL DYSFUNCTION IN DIABETES: AIMS 1-4
- Type2 Diabetes;Obesity;Type2 Diabetes;Obesity;Type2 Diabetes;Obesity;Type2 Diabetes;Obesity
- United States
- 2017-10-24
Recruiting
- Immunotherapy SBRT Sensitization of the Programmed Death-1 (PD-1) Effect
- Metastatic Nonsmall Cell Lung Cancer;Non Small Cell Lung Cancer
- United States
- 2017-08-18
Not recruiting
- Anti-inflammatory Therapy With Anakinra in Newly Diagnosed Type 1 Diabetes
- Type 1 Diabetes Mellitus
- United States
- 2008-03-25
Not recruiting
- The Effects of Alpha-1 Antitrypsin (AAT) on the Progression of Type 1 Diabetes
- Diabetes;Type 1 Diabetes;Diabetes;Type 1 Diabetes;Diabetes;Type 1 Diabetes;Diabetes;Type 1 Diabetes
- United States
- 2011-03-17
Not recruiting
- Stage 1 Study of ARALAST NP and GLASSIA in A1PI Deficiency
- Chronic Obstructive Pulmonary Disease;Alpha1-antitrypsin Deficiency
- Australia, Canada, United States
- 2016-03-23
Not recruiting
- Overall and Disease Specific Survival in Patients With Confirmed MEN1 With or Without PNET (Pancreatic Neuroendocrine Tumors)
- Genetic Mutation;MEN1
- United States
- 2017-02-02
Not recruiting
- Study of the Effect of Aerosolized, Recombinant Alpha 1-Antitrypsin on Epithelial Lining Fluid Analytes in Subjects With Alpha 1-Antitrypsin Deficiency
- Alpha 1-Antitrypsin Deficiency;Alpha 1-Antitrypsin Deficiency;Alpha 1-Antitrypsin Deficiency;Alpha 1-Antitrypsin Deficiency
- United States
- 2005-09-08
Not recruiting
- Safety Study of an Aerosolized, Recombinant Alpha 1-Antitrypsin in Subjects With Alpha 1-Antitrypsin Deficiency
- Alpha 1-antitrypsin Deficiency;Alpha 1-antitrypsin Deficiency;Alpha 1-antitrypsin Deficiency;Alpha 1-antitrypsin Deficiency
- United States
- 2005-09-08
Not recruiting
- A Phase 1 Open-Label Study of E7974 Administered on Days 1 and 15 of a 28-Day Cycle in Patients With Solid Malignancies
- Cancer, Malignant Tumors
- United States
- 2005-08-12
Not recruiting
- An Open-Label Study of E7974 Administered on Days 1, 8, and 15 of a 28-Day Cycle and Days 1 and 8 of a 21-Day Cycle in Patients With Solid Malignancies
- Solid Tumor Malignancies, Cancer
- United States
- 2005-07-15